TGFB1 and colorectal carcinoma: Another group has genetically dissected CRC progression (adenoma-carcinoma sequence) by orthotopic transplantation of CRISPR-engineered CRC organoids to study the contribution of common CRC key mutations (in Wnt, EGFR, P53, and TGF-β signalling pathways) to metastasis [23].